Accumulated Other Comprehensive Loss

6 Months Ended

Jan. 31, 2018

Accumulated Other Comprehensive Loss [Abstract]

Accumulated Other Comprehensive Loss

Note 9—Accumulated Other Comprehensive Loss

The accumulated balances for each classification of other comprehensive loss were as follows:

	Unrealized Gain (Loss) on Available-for-Sale Securities			Foreign Currency Translation			Accumulated Other Comprehensive Loss			Location of (Gain) Loss Recognized
	(in thousands)
Balance, July 31, 2017	$	2,134		$	(4,477	)	$	(2,343	)
Other comprehensive loss attributable to IDT Corporation before reclassifications		(159	)		(38	)		(197	)
Less: reclassification for loss included in net loss		9			—			9		Other income (expense), net
Net other comprehensive loss attributable to IDT Corporation		(150	)		(38	)		(188	)
Balance, January 31, 2018	$	1,984		$	(4,515	)	$	(2,531	)

At both January 31, 2018 and July 31, 2017, unrealized gain on available-for-sale securities included unrealized gain of $2.1 million on the Rafael Pharma Series D Note.